In CKD, systemic inflammation elevates pro-inflammatory cytokines such as IL-6 and TNF-α, which upregulate RANKL expression while suppressing OPG, a decoy receptor that curbs RANKL activity, thereby tipping the balance toward osteoclastogenesis (43). The gene discussed is IL6; the disease is chronic kidney disease.